Biotheranostics hologic login

WebJan 5, 2024 · – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in … WebFeb 22, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 million.Biotheranostics develops and markets two highly differentiated molecular …

Hologic to Acquire Molecular Diagnostics Firm Biotheranostics for …

WebFeb 22, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced … WebCancerTYPE ID ® is performed and billed separately by NeoGenomics’ contracted reference laboratory, Biotheranostics, Inc., an independent CLIA-licensed and CAP … green and white air jordans retro https://ateneagrupo.com

David Duvall - Senior Director, National Oncology Sales

WebJan 6, 2024 · On Monday, it announced acquisition of Somatex Medical for $64 million, a buy also in the women's health space. Hologic's $230 million valuation is roughly seven … WebJan 6, 2024 · M edical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth $230 million. Shares of Hologic, which closed 4% higher on Tuesday ... WebFeb 22, 2024 · - Breast Cancer Index ™ Added to National Comprehensive Cancer Network Guidelines to Predict Benefit from Extended Endocrine Therapy - Hologic, Inc. (Nasdaq: … flowers 90034

TEST REQUISITION FORM - Breast Cancer

Category:Visit the Hologic.com Customer Sign-in Page

Tags:Biotheranostics hologic login

Biotheranostics hologic login

CancerTYPE ID Hologic

WebJan 5, 2024 · Hologic, Inc., a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic ... http://www.biotheranostics.com/privacy-policy.html

Biotheranostics hologic login

Did you know?

WebApr 13, 2024 · Maryland Lab Permit-revised 04.13.2024 no expiration date.pdf. Pennsylvania Clinical Lab Permit-expires-08-15-2024.pdf.

http://www.biotheranostics.com/ WebJan 5, 2024 · On January 5, 2024, Hologic acquired life science company Biotheranostics for 230M USD Acquisition Highlights. This is Hologic’s 2nd transaction in the Life Science sector. This is Hologic’s 7th largest (disclosed) transaction. This is Hologic’s 15th transaction in the United States. This is Hologic’s 4th transaction in California.

WebCancerTYPE ID Hologic WebJan 6, 2024 · M edical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth $230 million. Shares of Hologic, …

WebNot Registered? Click here to start the process.. Loading

WebHologic announced a $230 million deal in which it will acquire Biotheranostics, a private company that provides molecular diagnostic tests for breast and metastatic cancers. Through the purchase, Hologic aims to enhance its current work in the field of oncology with more personalized treatment and better outcomes for women. flowers 939WebSign in or register to place Hologic product orders online (consumables only), download and view secure product documentation, search employment opportunities and set up job alerts or access training … green and white and orange flagWebBreast Cancer Index™ (BCI) is the only test recognized by NCCN Clinical Practice Guidelines in Oncology (NCCN ® Guidelines) and the American Society of Clinical … flowers 94107WebFeb 23, 2024 · February 23, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last ... green and white air fryerWebApr 3, 2024 · Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test. The firm said that the expanded coverage provides more women with access to a test that helps determine whether extended endocrine therapy is appropriate. Hologic Banking on MDx Acquisitions to Elevate Long-Term Revenue Growth. green and white and black jordansWebIn a clinical study of 547 patients considered to be clinically low risk (T1N0), Breast Cancer Index identified ~25% as likely to benefit from extended endocrine therapy and high risk of late distant recurrence. References: 1. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Breast ... flowers 94608WebJan 5, 2024 · Biotheranostics generated approximately $33 million of revenue in calendar 2024. The acquisition is expected to be slightly dilutive to Hologic’s non-GAAP earnings per share in fiscal 2024, break-even in 2024, and accretive thereafter. The acquisition is expected to close in February of 2024, subject to antitrust clearance and other customary ... green and white and green flag